Skip to content
Open access

Green Synthesis, In Silico Molecular Docking, and Evaluation of Pyrazole Derivatives for Their Antifungal and Antinemic Activity

Aug 2026 · Chemistry and Biodiversity · Vol 23 · 0 citations · 67 references
Medicine

TL;DR

Biological evaluation revealed that P‐25 [5‐(4‐fluorophenyl)‐1,3‐diphenyl‐1,3‐diphenyl‐1H‐pyrazole] exhibited the highest antifungal activity against Rhizoctonia solani, and molecular docking studies targeting succinate dehydrogenase (SDH) supported the experimental results.

Abstract

A series of 25 pyrazole derivatives was synthesized via ultrasonication‐assisted cyclization of chalcones with phenylhydrazine and characterized using 1H NMR, 13C NMR, and LC‐HRMS. Biological evaluation revealed that P‐25 [5‐(4‐fluorophenyl)‐1,3‐diphenyl‐1H‐pyrazole] exhibited the highest antifungal activity against Rhizoctonia solani (ED50 = 5.56 µg mL−1), approaching the efficacy of positive control hexaconazole 5% SC (ED50 = 3.67 µg mL−1). While P‐6 [5‐(3‐nitrophenyl)‐1,3‐diphenyl‐1H‐pyrazole] was most effective against Fusarium oxysporum (ED50 = 301.5 µg mL−1). In nematicidal assays, P‐21 [3‐(4‐ethoxyphenyl)‐5‐(4‐nitrophenyl)‐1‐phenyl‐1H‐pyrazole] showed the greatest activity against Meloidogyne incognita (LC50 = 31.25 µg mL−1, 24 h) although less potent than fluopyram 34.48% SC (Velum Prime) (LC50 = 3.46 µg mL−1). Molecular docking studies targeting succinate dehydrogenase (SDH) supported the experimental results, with P‐6, P‐25, and P‐21 exhibiting the strongest binding affinities against SDH of F. oxysporum (−8.3 kcal mol−1), R. solani (−8.3 kcal mol−1), and M. incognita (−7.7 kcal mol−1), respectively.

Read PDF

Similar papers

Open access Sep 2026

Novel Pyrazole‐4‐Carbaldehyde Derivatives Having Potent COX‐2 Inhibition and Anti‐Tubercular Activity: Microwave‐Assisted Green Synthesis and Molecular Docking

A series of 1‐(4‐Chorophenyl)‐3Aryl‐1‐H‐pyrazole‐4‐carbaldehyde derivatives synthesized under the microwave irradiation technique demonstrated their better‐fit potential as anti‐inflammatory agents and molecular docking studies demonstrated their better‐fit potential as anti‐inflammatory agents.

M. Kokane, Dnyandev Bhosale, Dattatraya G. Raut et al. · 0 citations
Open access Aug 2026

Synthesis, Crystal Structure, Antimicrobial Activity, and Computational Studies of Novel Pyridazine Derivatives

Two new pyridazinone derivatives, (E)‐4‐(4‐chlorobenzyl)‐6‐styrylpyridazin‐3(2H)‐one ( 2 ) and ethyl (E)‐2‐(5‐(4‐chlorobenzyl)‐6‐oxo‐3‐styrylpyridazin‐1(6H)‐yl)acetate ( 3 ), were synthesized and characterized using FT‐IR, 1 H NMR, 13 C NMR, and single‐crystal x‐ray diffraction. Their molecular properties w...

S. Daoui, I. el Houssni, S. Jeyavijayan et al. · 0 citations
Aug 2026

Synthesis of Novel 4,6‐Dimethoxyindole‐Based Hydrazones Derived From 2,4‐Dimethoxybenzaldehyde: Design, Cytotoxic Activity, Molecular Docking, and ADME‐Tox Studies

In silico ADME‐toxicity analyses predicted acceptable physicochemical and pharmacokinetic properties, supporting the potential of these derivatives as promising anticancer candidates.

Reşit Çakmak, Eyüp Başaran, Senem Akkoç et al. · 0 citations
Sep 2026

Synthesis, in Silico Therapeutic Target Screening Studies of Benzothiazolo[3,2‐a]Chromeno[4,3‐d]Pyrimidin Pharmacophore

The sustainable one‐pot multicomponent reaction between substituted aromatic aldehyde, 2‐aminobenzothiazole, and 4‐hydroxycoumarin molecules using β‐Cyclodextrin as an organocatalyst to synthesize benzothiazolo[3,2‐a]chromeno[4,3‐d]pyrimidin derivatives in excellent yield with short reaction time. Chiral HPLC analy...

Bhavana G. Polke, A. Jena, Mueataz G. Thabet et al. · 0 citations
Open access Sep 2026

Design and Synthesis of Novel 1,2,3‐Triazole Conjugates Featuring Hydroxamic Acid and Sulfonamide Moieties: Exploring Dual Pharmacophores for Enhanced Biological Activity

Computational studies supported the structural and pharmacokinetic characteristics of the synthesized compounds, with selected derivatives exhibiting favorable interactions with the c‐KIT kinase active site and generally acceptable drug‐like properties.

Dinesh Pagar, Ranjay Shaw, Hemant Suryavanshi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.